Medline (NASDAQ:MDLN) Major Shareholder Private Ltd Gic Sells 1,688,690 Shares of Stock

October 7, 2026 by InsiderTrades.com

Key Points

Private Ltd GIC sold 1.69 million Medline shares at an average price of $35.78, generating approximately $60.4 million and reducing its ownership by 8.35% to 18.54 million shares.
The shareholder has made several additional sales, including more than 9.27 million shares on October 6 and 7.15 million shares on October 2, potentially increasing near-term supply and weighing on investor sentiment.
Medline shares opened at $35.55, down 0.7%, while analysts maintained a “Moderate Buy” consensus with an average price target of $46.88. The company recently exceeded quarterly EPS expectations, but product-quality concerns and related investor investigations remain risks.

Medline (NASDAQ:MDLN - Get Free Report) major shareholder Private Ltd Gic sold 1,688,690 shares of the stock in a transaction on Monday, October 5th. The stock was sold at an average price of $35.78, for a total value of $60,421,328.20. Following the completion of the sale, the insider directly owned 18,542,793 shares in the company, valued at $663,461,133.54. This represents a 8.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.

A Fresh IPO That Long-Term Investors Shouldn’t Ignore

Private Ltd Gic also recently made the following trade(s):

On Tuesday, October 6th, Private Ltd Gic sold 7,183,013 shares of Medline stock. The shares were sold at an average price of $35.05, for a total transaction of $251,764,605.65.
On Tuesday, October 6th, Private Ltd Gic sold 2,088,987 shares of Medline stock. The stock was sold at an average price of $35.05, for a total transaction of $73,218,994.35.
On Friday, October 2nd, Private Ltd Gic sold 7,146,941 shares of Medline stock. The stock was sold at an average price of $34.33, for a total transaction of $245,354,484.53.
On Friday, August 14th, Private Ltd Gic sold 100,000 shares of Medline stock. The shares were sold at an average price of $35.80, for a total transaction of $3,580,000.00.
On Thursday, August 13th, Private Ltd Gic sold 1,500,000 shares of Medline stock. The shares were sold at an average price of $35.80, for a total transaction of $53,700,000.00.
On Friday, August 7th, Private Ltd Gic sold 590,284 shares of Medline stock. The shares were sold at an average price of $35.58, for a total transaction of $21,002,304.72.
On Thursday, August 6th, Private Ltd Gic sold 271,994 shares of Medline stock. The stock was sold at an average price of $35.33, for a total value of $9,609,548.02.
On Wednesday, August 5th, Private Ltd Gic sold 1,976,618 shares of Medline stock. The stock was sold at an average price of $35.60, for a total value of $70,367,600.80.

Medline Stock Down 0.7%

MDLN opened at $35.55 on Wednesday. Medline has a 12 month low of $31.49 and a 12 month high of $50.88. The company has a debt-to-equity ratio of 0.66, a current ratio of 4.33 and a quick ratio of 2.61. The stock has a market cap of $46.74 billion and a P/E ratio of 45.00. The stock's 50 day moving average price is $35.11 and its 200 day moving average price is $38.55.

Medline (NASDAQ:MDLN - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.32 by $0.18. The business had revenue of $7.68 billion for the quarter. As a group, research analysts predict that Medline will post 1.51 earnings per share for the current year.

Trending Headlines about Medline

Here are the key news stories impacting Medline this week:

Positive Sentiment: Medline announced that it will release third-quarter 2026 results before the market opens on November 4, followed by a conference call and webcast. The report could provide investors with updates on product-quality matters, demand, margins, and the company’s outlook. Medline third-quarter 2026 results announcement
Neutral Sentiment: Pomerantz, Kaplan Fox, Kirby McInerney, and Bleichmar Fonti & Auld announced investigations related to Medline’s disclosures about manufacturing and product quality following a significant share-price decline. These announcements are largely investor-solicitation notices, and the articles do not establish wrongdoing or indicate that a lawsuit has been filed. Pomerantz Medline investor alert
Negative Sentiment: Major shareholder Private Ltd GIC sold 2.09 million Medline shares for approximately $73.2 million on October 6 at an average price of $35.05, reducing its position by 11.27%. The shareholder also sold 1.69 million shares for about $60.4 million on October 5, cutting its holdings by 8.35%. The combined sales may weigh on sentiment because they signal insider-level selling and increase near-term supply, although the filings do not give a reason for the transactions. SEC ownership filing
Negative Sentiment: The reported product-quality concerns and resulting securities investigations raise uncertainty around potential recalls, regulatory scrutiny, litigation costs, and damage to Medline’s reputation. Until the company provides additional details, these risks are likely to remain an overhang on MDLN.

Institutional Trading of Medline

Hedge funds and other institutional investors have recently modified their holdings of the business. Capital Research Global Investors purchased a new position in shares of Medline during the fourth quarter valued at $620,937,000. Artisan Partners Limited Partnership purchased a new stake in Medline in the 4th quarter worth about $192,847,000. Healthcare of Ontario Pension Plan Trust Fund boosted its position in Medline by 233.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 5,000,000 shares of the company's stock worth $222,500,000 after acquiring an additional 3,500,000 shares during the period. Bessemer Group Inc. boosted its position in Medline by 39,404.0% during the 1st quarter. Bessemer Group Inc. now owns 3,504,006 shares of the company's stock worth $155,929,000 after acquiring an additional 3,495,136 shares during the period. Finally, Capital World Investors purchased a new position in Medline during the 4th quarter valued at about $142,446,000.

Analyst Upgrades and Downgrades

MDLN has been the subject of a number of research analyst reports. William Blair restated an "outperform" rating on shares of Medline in a research report on Wednesday, September 23rd. Tigress Financial dropped their price objective on Medline from $62.00 to $55.00 and set a "buy" rating on the stock in a research note on Tuesday, August 11th. Deutsche Bank Aktiengesellschaft set a $37.00 price objective on Medline in a report on Thursday, August 6th. Evercore set a $39.00 price objective on shares of Medline in a research report on Thursday, August 6th. Finally, UBS Group reduced their target price on Medline from $45.00 to $43.00 and set a "buy" rating for the company in a report on Friday, September 25th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Medline has an average rating of "Moderate Buy" and a consensus price target of $46.88.

Read Our Latest Stock Analysis on MDLN

About Medline

(Get Free Report)

Medline Industries, Inc is a healthcare company that manufactures and distributes medical supplies, clinical products and equipment to hospitals, health systems, physician practices, long-term care facilities, surgery centers and other healthcare providers. Its offerings are designed to support patient care, surgical procedures, infection prevention and healthcare facility operations.

The company's product portfolio includes surgical instruments and supplies, exam gloves and protective apparel, wound care products, patient-care items, respiratory and monitoring equipment, laboratory supplies, durable medical equipment and products for environmental and facility management.